Familial non-autoimmune hyperthyroidism caused by an activating TSHR mutation: A case report

Nguyen Hoang Lan, Vu Chi Dung

Main Article Content

Abstract

Non-autoimmune hyperthyroidism (NAH) is a rare disorder caused by activating mutations of the thyroid-stimulating hormone receptor (TSHR) gene. Current evidence on this disease is largely based on case reports and small series, reflecting the rarity of reported cases worldwide. We report the case of a 2-year-old girl who developed bilateral exophthalmos at 7 months of age, followed by tremor, tachycardia, and poor weight gain. Laboratory investigations revealed overt hyperthyroidism with a thyroid-stimulating hormone (TSH) level of < 0.005 mIU/L, free thyroxine (FT4) level > 100 pmol/L, and triiodothyronine (T3) level of 9.31 nmol/L, while thyroid autoantibodies were negative. Family history revealed multiple affected individuals with hyperthyroidism across successive generations, suggesting an autosomal dominant pattern of inheritance. Genetic analysis identified a heterozygous TSHR variant, c.1514G>A (p.Ser505Asn), which was classified as a likely pathogenic variant. The patient was treated with methimazole and propranolol and showed a favorable response, with improvement in thyroid function tests after 15 months of follow-up. This case highlights the importance of considering a genetic etiology in children presenting with early-onset hyperthyroidism, particularly in the presence of negative thyroid autoantibodies and a compatible family history.

Article Details

References

1. Takahashi S, Nishihara E, Fukata S, Miyauchi A, Akamizu T. Familial Nonautoimmune Hyperthyroidism Due to a TSH Receptor Gene Pathogenic Variant. JCEM Case Reports. 2024;2(10):luae167. doi:10.1210/jcemcr/luae 167
2. Hébrant A, van Staveren WCG, Maenhaut C, Dumont JE, Leclère J. Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations. Eur J Endocrinol. 2011;164(1):1-9. doi:10.1530/EJE-10-0775
3. Paschke R, Niedziela M, Vaidya B, Persani L, Rapoport B, Leclere J. 2012 European Thyroid Association Guidelines for the Management of Familial and Persistent Sporadic Non-Autoimmune Hyperthyroidism Caused by Thyroid-Stimulating Hormone Receptor Germline Mutations. Eur Thyroid J. 2012;1(3):142-147. doi:10.1159/000342982
4. Suput Omladic J, Pajek M, Groselj U, et al. Central TSH Dysregulation in a Patient with Familial Non-Autoimmune Autosomal Dominant Hyperthyroidism Due to a Novel Thyroid-Stimulating Hormone Receptor Disease-Causing Variant. Medicina. 2021;57(3):196. doi:10.3390/medicina57030196
5. Yamichannaiah C, Memon SS, Sarathi V, et al. Genotype-Phenotype Correlation in Germline TSH Receptor Activating Mutation Associated Hyperthyroidism: A Systematic Review. Clin Endocrinol (Oxf). 2025;103(2):119-128. doi:10.1111/cen.15288
6. Thomas JS, Leclere J, Hartemann P, et al. Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol (Copenh). 1982;100(4):512-518. doi:10.1530/acta.0.1000512
7. Führer D, Mix M, Wonerow P, Richter I, Willgerodt H, Paschke R. Variable phenotype associated with Ser505Asn-activating thyrotropin-receptor germline mutation. Thyroid. 1999;9(8):757-761. doi:10.1089/thy.1999.9.757
8. Holzapfel HP, Wonerow P, von Petrykowski W, Henschen M, Scherbaum WA, Paschke R. Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. J Clin Endocrinol Metab. 1997;82(11):3879-3884. doi:10.1210/jcem.82.11.4378
9. Paschke R, Ludgate M. The thyrotropin receptor in thyroid diseases. N Engl J Med. 1997;337(23):1675-1681. doi:10.1056/NEJM19 9712043372307
10. Grüters A. Ocular manifestations in children and adolescents with thyrotoxicosis. Exp Clin Endocrinol Diabetes. 1999;107 Suppl 5:S172-174. doi:10.1055/s-0029-1212178